Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
  • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
  • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
  • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
  • A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
  • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
  • Y10S530/827—Proteins from mammals or birds
  • Y10S530/828—Cancer

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Medicinal Chemistry (AREA)
• Public Health (AREA)
• Pharmacology & Pharmacy (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Immunology (AREA)
• Veterinary Medicine (AREA)
• Epidemiology (AREA)
• Microbiology (AREA)
• Mycology (AREA)
• Peptides Or Proteins (AREA)
• Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicinal Preparation (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)
• Indole Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Materials For Medical Uses (AREA)
• Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Applications Claiming Priority (1)

Publications (2)

Family

ID=10540516

Family Applications (1)

Country Status (24)

Families Citing this family (24)

Family Cites Families (10)

• 1984
  • 1984-03-26 GB GB08407766A patent/GB2137210B/en not_active Expired
  • 1984-03-26 DK DK167884A patent/DK167884A/da not_active IP Right Cessation
  • 1984-03-26 DE DE8484302004T patent/DE3482444D1/de not_active Expired - Fee Related
  • 1984-03-26 GR GR74217A patent/GR79899B/el unknown
  • 1984-03-26 AT AT84302004T patent/ATE53496T1/de not_active IP Right Cessation
  • 1984-03-26 EP EP84302004A patent/EP0121388B1/en not_active Expired - Lifetime
  • 1984-03-27 AU AU26143/84A patent/AU570963B2/en not_active Ceased
  • 1984-03-27 IL IL71366A patent/IL71366A/xx unknown
  • 1984-03-27 CA CA000450616A patent/CA1210696A/en not_active Expired
  • 1984-03-27 PT PT78322A patent/PT78322B/pt not_active IP Right Cessation
  • 1984-03-28 PH PH30460A patent/PH23222A/en unknown
  • 1984-03-28 NZ NZ207675A patent/NZ207675A/en unknown
  • 1984-03-28 EG EG202/84A patent/EG16175A/xx active
  • 1984-03-29 SU SU843721031A patent/SU1362404A3/ru active
  • 1984-03-29 PL PL1984246931A patent/PL144887B1/pl unknown
  • 1984-03-29 ZA ZA842347A patent/ZA842347B/xx unknown
  • 1984-03-29 HU HU841259A patent/HU191647B/hu not_active IP Right Cessation
  • 1984-03-29 IE IE772/84A patent/IE57218B1/xx unknown
  • 1984-03-29 ES ES531081A patent/ES531081A0/es active Granted
  • 1984-03-29 FI FI841260A patent/FI80383C/fi not_active IP Right Cessation
  • 1984-03-29 BG BG8464893A patent/BG42837A3/xx unknown
  • 1984-03-30 JP JP59063140A patent/JPS59190924A/ja active Pending
  • 1984-03-30 KR KR1019840001690A patent/KR890002634B1/ko not_active IP Right Cessation
• 1986
  • 1986-06-23 US US06/877,598 patent/US4845200A/en not_active Expired - Lifetime

Also Published As

Similar Documents

Legal Events